Clinical Trial Update: Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing clonidine to phenobarbital as adjunctive therapy for neonatal abstinence syndrome has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome

Drugs mentioned

• Clonidine (clonidine)
• Phenobarbital (phenobarbital)

Snippet

Sponsor: University of Tennessee Medical Center | Conditions: Neonatal Abstinence Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-11-09